化学&生物药
在化学&生物药领域，最新融资动态显示：Khartis THERAPEUTICS Inc完成B轮融资，投资方为Forge Life Science Partners、礼来亚洲基金、Nextech Invest、Foresite Capital、Alexandria Venture Investments、Longwood Fund。更多详细融资信息，可通过专题列表查阅。
2026-08-13
口服小分子药物开发商
医药研发/制造
化学&生物药
Forge Life Science Partners;
Forge Life Science Partners;
礼来亚洲基金;
礼来亚洲基金;
Nextech Invest;
Foresite Capital;
Alexandria Venture Investments;
Longwood Fund;
2026-08-12
免疫系统疾病类抗体药物研发商
医药研发/制造
化学&生物药
Regeneron Ventures;
Regeneron Ventures;
Playground Global;
Playground Global;
RA Capital;
Merck GHI Fund;
Goldcrest Capital;
Forge Life Science Partners;
Godfrey Capital;
Civilization Ventures;
Pear Ventures;
2026-08-12
双特异性抗体药物研发商
医药研发/制造
化学&生物药
The Column Group;
The Column Group;
Eli Lilly;
Eli Lilly;
赛诺菲;
Solasta Ventures;
Euclidean Capital;
Emerson Collective;
MRL Ventures Fund;
Vida Ventures;
2026-08-11
罕见血管疾病靶向疗法开发商
医药研发/制造
化学&生物药
TCGX;
TCGX;
DROIA;
DROIA;
Medicxi Ventures;
Kalehua Capital;
Perceptive Advisors;
EQT Partners;
Omega Funds;
2026-08-11
基因技术研发商
医药研发/制造
化学&生物药
Janus Henderson Investors;
Janus Henderson Investors;
八方资本;
八方资本;
abrdn;
Angelini Ventures;
赛诺菲;
Duquesne Family Office;
鱼鹰资管;
富达国际;